Ptc Therapeutics (PTCT) Current Taxes (2019 - 2025)

Ptc Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $4.7 million for Q4 2025.

• On a quarterly basis, Current Taxes fell 0.51% year-over-year to $4.7 million in Q4 2025; TTM through Dec 2025 was $4.7 million, a 0.51% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 0.51% from the prior year.
• Current Taxes grew to $4.7 million in Q4 2025 per PTCT's latest filing, from $2.9 million in the prior quarter.
• Across five years, Current Taxes topped out at $64.6 million in Q1 2025 and bottomed at $618000.0 in Q2 2021.
• The 5-year median for Current Taxes is $4.7 million (2025), against an average of $10.0 million.
• Across the five-year window, Current Taxes slumped 70.17% in 2021 and surged 3425.48% in 2025, its largest moves.
• Year by year, Current Taxes stood at $1.3 million in 2021, then jumped by 266.12% to $4.7 million in 2022, then sank by 40.11% to $2.8 million in 2023, then surged by 66.58% to $4.7 million in 2024, then fell by 0.51% to $4.7 million in 2025.
• Per Business Quant, the three latest PTCT Current Taxes figures stand at $4.7 million (Q4 2025), $2.9 million (Q3 2025), and $39.9 million (Q2 2025).